Clinical trial
LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS (CTC) AND CIRCULATING TUMOR DNA (CTDNA) AS A PRECISION MEDICINE TOOL IN GASTROINTESTINAL TUMORS
NCT06940778 is registered in ClinicalTrials.gov with Hospital do Coracao as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS (CTC) AND CIRCULATING TUMOR DNA (CTDNA) AS A PRECISION MEDICINE TOOL IN GASTROINTESTINAL TUMORS
- Lead sponsor
- Hospital do Coracao
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 10, 2025
- Completion date
- December 10, 2026
- Enrollment
- 273 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer of pancreas, cancer of rectum, cancer of stomach